WBH Advisory Inc. Decreases Holdings in Danaher Co. (NYSE:DHR)

WBH Advisory Inc. lowered its stake in Danaher Co. (NYSE:DHR) by 10.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,611 shares of the conglomerate’s stock after selling 308 shares during the period. WBH Advisory Inc.’s holdings in Danaher were worth $599,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. AMF Tjanstepension AB acquired a new stake in shares of Danaher in the third quarter worth $5,923,000. Creative Planning grew its position in Danaher by 3.1% during the third quarter. Creative Planning now owns 126,340 shares of the conglomerate’s stock valued at $35,125,000 after buying an additional 3,749 shares during the period. Good Life Advisors LLC acquired a new stake in Danaher during the third quarter valued at $217,000. Howard Capital Management Group LLC grew its position in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares during the period. Finally, Cyndeo Wealth Partners LLC grew its position in Danaher by 9.7% during the third quarter. Cyndeo Wealth Partners LLC now owns 8,425 shares of the conglomerate’s stock valued at $2,342,000 after buying an additional 748 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent analyst reports. Guggenheim initiated coverage on shares of Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. UBS Group decreased their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. KeyCorp increased their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Stock Up 1.5 %

Danaher stock opened at $206.66 on Tuesday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The stock’s fifty day simple moving average is $229.53 and its 200-day simple moving average is $249.13. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $149.26 billion, a P/E ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm earned $2.09 EPS. As a group, equities analysts expect that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.